ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Centro de Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique.
Front Immunol. 2019 Mar 15;10:439. doi: 10.3389/fimmu.2019.00439. eCollection 2019.
Naturally acquired immunity (NAI) to malaria is mainly mediated by IgG antibodies but the subclasses, epitope targets and effector functions have not been unequivocally defined. Dissecting the type and specificity of antibody responses mediating NAI is a key step toward developing more effective vaccines to control the disease. We investigated the role of IgG subclasses to malaria antigens in protection against disease and the factors that affect their levels, including vaccination with RTS,S/AS01E. We analyzed plasma and serum samples at baseline and 1 month after primary vaccination with RTS,S or comparator in African children and infants participating in a phase 3 trial in two sites of different malaria transmission intensity: Kintampo in Ghana and Manhiça in Mozambique. We used quantitative suspension array technology (qSAT) to measure IgG responses to 35 pre-erythrocytic and blood stage antigens. Our results show that the pattern of IgG response is predominantly IgG1 or IgG3, with lower levels of IgG2 and IgG4. Age, site and RTS,S vaccination significantly affected antibody subclass levels to different antigens and susceptibility to clinical malaria. Univariable and multivariable analysis showed associations with protection mainly for cytophilic IgG3 levels to selected antigens, followed by IgG1 levels and, unexpectedly, also with IgG4 levels, mainly to antigens that increased upon RTS,S vaccination such as MSP5 and MSP1 block 2, among others. In contrast, IgG2 was associated with malaria risk. Stratified analysis in RTS,S vaccinees pointed to novel associations of IgG4 responses with immunity mainly involving pre-erythrocytic antigens upon RTS,S vaccination. Multi-marker analysis revealed a significant contribution of IgG3 responses to malaria protection and IgG2 responses to malaria risk. We propose that the pattern of cytophilic and non-cytophilic IgG antibodies is antigen-dependent and more complex than initially thought, and that mechanisms of both types of subclasses could be involved in protection. Our data also suggests that RTS,S efficacy is significantly affected by NAI, and indicates that RTS,S vaccination significantly alters NAI.
自然获得性免疫(NAI)对疟疾主要由 IgG 抗体介导,但亚类、表位靶点和效应功能尚未明确界定。解析介导 NAI 的抗体反应的类型和特异性是开发更有效疫苗控制疾病的关键步骤。我们研究了 IgG 亚类对疟疾抗原在保护中的作用,以及影响其水平的因素,包括用 RTS,S/AS01E 进行疫苗接种。我们分析了在加纳的 Kintampo 和莫桑比克的 Manhiça 两个疟疾传播强度不同的地点参与 3 期试验的非洲儿童和婴儿在初次接种 RTS,S 或对照疫苗后 1 个月时的血浆和血清样本。我们使用定量悬浮阵列技术(qSAT)测量了对 35 种原虫期和血期抗原的 IgG 反应。我们的结果表明,IgG 反应模式主要是 IgG1 或 IgG3,IgG2 和 IgG4 水平较低。年龄、地点和 RTS,S 疫苗接种显著影响了对不同抗原的抗体亚类水平和对临床疟疾的易感性。单变量和多变量分析显示,与保护相关的主要是对选定抗原的亲细胞 IgG3 水平,其次是 IgG1 水平,出乎意料的是,还与 IgG4 水平相关,主要与 RTS,S 接种后增加的抗原相关,如 MSP5 和 MSP1 块 2 等。相比之下,IgG2 与疟疾风险相关。RTS,S 疫苗接种者的分层分析表明,IgG4 反应与 RTS,S 接种后主要涉及原虫期抗原的免疫之间存在新的关联。多标志物分析显示 IgG3 反应对疟疾保护有显著贡献,而 IgG2 反应对疟疾风险有显著贡献。我们提出,亲细胞和非亲细胞 IgG 抗体的模式是抗原依赖性的,比最初想象的更为复杂,两种类型的亚类的机制都可能参与保护。我们的数据还表明,RTS,S 的疗效受到 NAI 的显著影响,并表明 RTS,S 疫苗接种显著改变了 NAI。